Centiva Capital’s Medtronic MDT Stock Holding History

Centiva Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.22M	Buy	+60,200	New	+$5.77M	0.04%	269
2024 Q4	–	Sell	-5,000	Closed	-$450K	–	2114
2024 Q3	$450K	Hold	5,000	–	–	0.01%	1318
2024 Q2	$394K	Buy	+5,000	New	+$410K	0.01%	1306
2022 Q4	–	Sell	-15,000	Closed	-$1.21M	–	1520
2022 Q3	$1.21M	Buy	+15,000	New	+$1.35M	0.02%	531
2021 Q4	–	Sell	-20	Closed	-$3K	–	1409
2021 Q3	$3K	Buy	+20	New	+$2.59K	﹤0.01%	1231

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Centiva Capital's MDT Position: Q1 2026 in Review

Centiva Capital opened a new position in Medtronic (MDT) in Q1 2026: 22,333 shares worth $1.94M. The stake represents 0.01% of the portfolio and ranks #439 among its holdings. This is a return to the name: Centiva Capital previously reported a position in MDT as recently as Q1 2025.

Centiva Capital first reported a position in MDT in Q4 2019 and has held it in 18 quarters since. The position peaked at $6.94M in Q3 2024. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Centiva Capital held 22,333 shares of Medtronic worth $1.94M as of Q1 2026.
Medtronic was a new Centiva Capital position in Q1 2026.
Medtronic made up 0.01% of Centiva Capital's portfolio in Q1 2026, its #439 holding.
Centiva Capital first reported a position in Medtronic in Q4 2019 and has held it in 18 quarters since.
Centiva Capital's Medtronic position peaked at $6.94M in Q3 2024.
2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Centiva Capital's 13F filing for Q1 2026, filed 14 May 2026.